-
Cyclodextrin Market to Set an Explosive Growth in Near Future| Cambrex Corporation, Roquette Frères, Cayman Chemical
27 Jan 2025 07:36 GMT
… sector.
Leading Market Players: -
Cambrex Corporation
Cayman Chemical
Wellona Pharma
Wacker …
-
Pharmaceutical Stability And Storage Services Market Growth Drivers, and Future Projections (2024-2034) at an 8.5% CAGR
29 Aug 2025 05:35 GMT
… LLC
Almac Group
WuXi AppTec
Cambrex Corporation
Catalent, Inc.
PCI Pharma Services …
-
Global Pharmaceutical Contract Manufacturing Market to Surpass the USD 360 Billion Mark by 2032 | DelveInsight
28 Aug 2025 23:47 GMT
… , Laboratoire Elaiapharm, The Lubrizol Corporation, Cambrex Corporation, Recipharm (EQT), Merck & Co … Solutions (Baxter), iBio., Catalent, Inc., Cambrex Corporation, Pfizer Inc., among others.
Biologics …
-
Global Pharmaceuticals Market to Register Immense Growth at a CAGR of ~7% by 2032 | DelveInsight
27 Aug 2025 17:00 GMT
… , Laboratoire Elaiapharm, The Lubrizol Corporation, Cambrex Corporation, Recipharm (EQT), Merck & Co … Solutions (Baxter), iBio., Catalent, Inc., Cambrex Corporation, Pfizer Inc., among others. Biologics …
-
Semi-Solid Dosage Contract Manufacturing Market to Reach $26.76B by 2029 | Exclusive Report by TBRC
25 Aug 2025 03:33 GMT
… AB
• Piramal Pharma Solutions Inc.
• Cambrex Corporation
• Sharp Services
• ANI Pharmaceuticals
• Pierre …
-
Peptide Therapeutics Contract Active Pharmaceutical Ingredient (API) Manufacturing Industry Report
22 Aug 2025 17:33 GMT
… AG.
• WuXi AppTec Co. Ltd.
• Cambrex Corporation
• ChemPartner
• GenScript Biotech Corporation
• Bachem …
-
Cyclodextrin Market Investment Report: Growth Opportunities and Strategic Insights, 2032
22 Aug 2025 09:38 GMT
… -A107969
Leading Market Players: -
Cambrex Corporation
Cayman Chemical
Wellona Pharma
Wacker …
-
Global Personal Care Contract Manufacturing Market To Cross USD 40 Billion By 2032 Delveinsight
19 Aug 2025 23:45 GMT
… , Laboratoire Elaiapharm, The Lubrizol Corporation, Cambrex Corporation, Recipharm (EQT), Merck & Co … Solutions (Baxter), iBio., Catalent, Inc., Cambrex Corporation, Pfizer Inc. , among others.
Biologics …
-
U.S. Active Pharmaceutical Ingredients CDMO Market Trends Analysis Report 2025-2030 | Biologics Investment, Chronic Disease Burden, and Innovation Needs Bolster Growth - ResearchAndMarkets.com
15 Aug 2025 13:51 GMT
… Inc.
Novo Group (Catalent, Inc.)
Cambrex Corporation
Piramal Pharma Limited
Corden Pharma …
-
Active Pharmaceutical Ingredients (API) Market Forecast to Cross US$ 466.9 Bn by 2035 – Transparency Market Research
14 Aug 2025 21:28 GMT
…
Biocon
Merck KGaA
Boehringer Ingelheim
Cambrex Corporation
Dr. Reddy’s Laboratories Ltd …
About
© 1995-2025